Aker BioMarine reports 17% revenue growth in 2020 amid krill EPA/DHA launch and COVID-19 hurdles

The company also entered a research collaboration for its Lysoveta krill ingredient’s potential for Alzheimer’s

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

01 Mar 2021 --- Consumers increasingly turn to sleep and relaxations supplements to tackle COVID-19 stress and this market is pegged for further growth in 2021, according to... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

24 Feb 2021 --- Research from infant formula producer Abbott has revealed human milk oligosaccharides (HMOs) may not only support babies’ immune health, but also their... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

22 Feb 2021 --- The US Food and Drug Administration (FDA) has issued warning letters to ten companies for illegally selling dietary supplements that claim to cure, treat, mitigate... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

18 Feb 2021 --- Spain-based Noventure has signed an exclusivity agreement with Azur – a division of Solutex – for the licensing rights of EPA3G, a patented emulsion of... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

05 Feb 2021 --- Garden of Life has launched a line of six supplements for US babies, targeting aspects of health from digestion and immunity to cognition. Each offering comes with... Read More

trans